EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Remimazolam Bolus Prevents Emergence Agitation After Rhinologic Surgery: A Randomized, Triple-Blind, Controlled Trial

Grgur Prižmić iD, Filip Periš, Marinela Jozeljić Pešić iD, Ana Maria Mitar iD, Ana Bego iD, Sanja Pavičić Perković iD, Sanda Stojanović Stipić iD

Medical Sciences · 2026

DOI: 10.3390/medsci14010129 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Medical Sciences, 2026. Verfasst von Grgur Prižmić und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anaesthesiology, Division of Anaesthesiology, University Hospital of Split, 21000 Split, Croatia. Hauptthemen laut MEDLINE: Benzodiazepines, Emergence Delirium, Nasal Surgical Procedures. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Objectives: Emergence agitation (EA) is common after rhinologic surgery and may cause self-injury, bleeding, and prolonged post-anesthesia care unit (PACU) stay. Remimazolam is an ultra-short-acting benzodiazepine that may reduce EA without delaying recovery. The objective of this study was to evaluate the effect of a single dose of remimazolam administered at the end of surgery on the incidence of EA in adult patients undergoing nasal surgery.

Methods

In this prospective, randomized, triple-blind, placebo-controlled trial, 62 adults undergoing elective rhinologic surgery under sevoflurane anesthesia received either remimazolam 0.1 mg/kg or saline immediately after sevoflurane discontinuation and before extubation. EA was assessed using the Richmond Agitation–Sedation Scale (RASS) at extubation and every 5 min for 30 min in the PACU. The primary outcome was presence of EA (RASS ≥ 2) at extubation. Secondary outcomes included Aldrete recovery scores, VAS, PONV incidence and safety outcomes. The study was registered at ClinicalTrials.gov (NCT06398275; 3 May 2024).

Results

EA occurred in 12/32 patients (37.5%) in the control group and 0/30 (0%) in the remimazolam group (p < 0.001). Extubation time and operative durations were similar between groups. More patients in the remimazolam group achieved an Aldrete score ≥ 9 at extubation (76.7% vs. 50.0%, p = 0.030). Severe agitation (RASS ≥ 3) requiring rescue sedation occurred in 6/32 control-group patients and in 0/30 patients in the remimazolam group (p = 0.025). Pain scores were low (no VAS > 2). PONV occurred in one patient per group. Clinically relevant postoperative nasal bleeding requiring intervention occurred in 2/32 control-group patients and in 0/30 remimazolam-group patients. No laryngospasm or respiratory complications within 24 h were observed.

Conclusions

A single remimazolam bolus given at the end of surgery prevented clinically relevant EA after rhinologic surgery without delaying early recovery.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BenzodiazepinesEmergence DeliriumNasal Surgical ProceduresHumansFemaleMaleMiddle AgedAdultSevofluraneProspective StudiesAnesthesia Recovery Period

Stichwörter der Autor:innen

emergence agitationpost-anesthesia care unitrandomized controlled trialremimazolamrhinologic surgerysevoflurane

Substanzen

BenzodiazepinesSevoflurane

Autor:innen und Institutionen

  • Department of Anaesthesiology, Division of Anaesthesiology, University Hospital of Split, 21000 Split, Croatia.
  • School of Medicine, University of Split, 21000 Split, Croatia.

ORCID-Profile: Grgur Prižmić, Marinela Jozeljić Pešić, Ana Maria Mitar, Ana Bego, Sanja Pavičić Perković, Sanda Stojanović Stipić

Zitieren

APA

Prižmić, G., Periš, F., Jozeljić Pešić, M., Mitar, A. M., Bego, A., Perković, S. P., & Stojanović Stipić, S. (2026). Remimazolam Bolus Prevents Emergence Agitation After Rhinologic Surgery: A Randomized, Triple-Blind, Controlled Trial. Medical Sciences. https://doi.org/10.3390/medsci14010129

Vancouver

Prižmić G, Periš F, Jozeljić Pešić M, Mitar AM, Bego A, Perković SP, et al. Remimazolam Bolus Prevents Emergence Agitation After Rhinologic Surgery: A Randomized, Triple-Blind, Controlled Trial. Medical Sciences. 2026. doi:10.3390/medsci14010129

BibTeX
@article{Primi2026,
  author = {Prižmić, Grgur and Periš, Filip and Jozeljić Pešić, Marinela and Mitar, Ana Maria and Bego, Ana and Perković, Sanja Pavičić and Stojanović Stipić, Sanda},
  title = {Remimazolam Bolus Prevents Emergence Agitation After Rhinologic Surgery: A Randomized, Triple-Blind, Controlled Trial},
  journal = {Medical Sciences},
  year = {2026},
  doi = {10.3390/medsci14010129}
}
Kostenlos starten →